Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Matthew W. Trinder"'
Publikováno v:
JGH Open, Vol 4, Iss 2, Pp 140-144 (2020)
Background and Aim Severe ulcerative colitis (UC) is potentially life threatening and is associated with significant morbidity. TNF‐∝ inhibitors (Infliximab) were introduced in Australia for the management of medically resistant, acute, severe fl
Externí odkaz:
https://doaj.org/article/dcf44b6ad2b541399f63ed799853108e
Autor:
Guy H. M. Stanley, Tristan Gilliland, Matthew W. Trinder, Enoch Wong, Yu Xin Liew, Jennifer Ryan
Publikováno v:
ANZ Journal of Surgery. 92:2701-2703
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41d8d23a912598e390c4e1ec5d85a81d
https://doi.org/10.1111/ans.17930
https://doi.org/10.1111/ans.17930
Publikováno v:
ANZ Journal of Surgery. 92:397-402
Sarcopenia is an independent predictor of poor post-operative outcomes following major surgery. Inflammatory bowel disease (IBD) consists of Crohn's disease (CD) and ulcerative colitis (UC), which are chronic inflammatory conditions involving the gas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8977bcde4f16178b316362cf0d9e4d49
https://doi.org/10.1111/ans.17439
https://doi.org/10.1111/ans.17439
Publikováno v:
EJVES Short Reports
Introduction The management of peri-aortitis, a rare complication after endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA), is described in a patient with a solitary kidney. Report A 64 year old man who developed peri-aortitis af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f02125100218a921b7b8c3b3a59afdeb
https://doi.org/10.1016/j.ejvssr.2019.10.002
https://doi.org/10.1016/j.ejvssr.2019.10.002
Publikováno v:
ANZ Journal of Surgery. 91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::047bd9ec438dd7e6df7f2d76a6c13865
https://doi.org/10.1111/ans.16624
https://doi.org/10.1111/ans.16624
Publikováno v:
ANZ Journal of Surgery. 91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a672f514871048f1b8d6a622747230
https://doi.org/10.1111/ans.16594
https://doi.org/10.1111/ans.16594
Publikováno v:
ANZ Journal of Surgery. 92:921-922
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2938e5e1344039996a309ea86e682b3
https://doi.org/10.1111/ans.17206
https://doi.org/10.1111/ans.17206
Autor:
Ian C. Lawrance, Matthew W. Trinder
Publikováno v:
Journal of gastroenterology and hepatology. 24(7)
Background: Anti-tumor necrosis factor (TNF)-alpha medications are effective in Crohn's Disease (CD) and efficacious in ulcerative colitis (UC). Adalimumab has been available through the Australian Pharmaceutical Benefits Scheme since August 2008, bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23275d92ec26290ee6c5114bbcb607ff
https://pubmed.ncbi.nlm.nih.gov/19682189
https://pubmed.ncbi.nlm.nih.gov/19682189